NeoGenomics, Inc. Payments To Acquire Equity Securities Fv Ni
NeoGenomics, Inc. (NEO) reported Payments To Acquire Equity Securities Fv Ni of $500.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquitySecuritiesFvNi · last filed 2026-02-17
- NeoGenomics, Inc. payments to acquire equity securities fv ni for the quarter ending 2025-12-31 was $0.00.
- NeoGenomics, Inc. payments to acquire equity securities fv ni for the quarter ending 2024-12-31 was $0.00.
- NeoGenomics, Inc. payments to acquire equity securities fv ni for fiscal 2025 was $500.00K.
- NeoGenomics, Inc. payments to acquire equity securities fv ni for fiscal 2024 was $0.00.
- NeoGenomics, Inc. payments to acquire equity securities fv ni for fiscal 2023 was $0.00.
| Period end | Payments To Acquire Equity Securities Fv Ni 3 month | Payments To Acquire Equity Securities Fv Ni 9 month | Payments To Acquire Equity Securities Fv Ni 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $500.00K 10-K · filed 2026-02-17 | |
| 2025-09-30 | $500.00K 10-Q · filed 2025-10-28 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $0.00 10-K · filed 2026-02-17 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-10-28 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |